Fludarabine, Arabinosyl Cytosine and Idarubicin (FLAI) for Remission Induction in Poor-Risk Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Fludarabine, Arabinosyl Cytosine and Idarubicin (FLAI) for Remission Induction in Poor-Risk Acute Myeloid Leukemia

Published:2001-01 Issue:3-4 Volume:40 Page:335-343
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Russo Domenico,Pricolo Giancarla,Michieli Mariagrazia,Michelutti Angela,Raspadori Donatella,Bertone Antonella,Marin Luciana,Pierri Ivana,Bucalossi Alessandro,Zuffa Eliana,Vivo Antonio De,Mazza Patrizio,Gobbi Marco,Lauria Francesco,Zaccaria Alfonso,Baccarani Michele

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428190109057932

Reference45 articles.

1. Long-term survival of patients with acute myeloid leukemia

2. Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy

3. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity

4. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia;Journal of Oncology;2019-10-30

2. Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives;BioScience Trends;2017

3. MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis;Molecular Cytogenetics;2016-09-01

4. Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia;Annals of Hematology;2016-08-19

5. Older and new purine nucleoside analogs for patients with acute leukemias;Cancer Treatment Reviews;2013-12